Labeler
Amgen, Inc NDC Codes
Amgen, Inc lists 87 finished drug products in the FDA NDC Directory under NDC labeler code 55513.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Aranesp, Amjevita, Otezla, Epogen, Aimovig, Neupogen, Neulasta, Evenity, Lumakras, Nplate, Corlanor, Parsabiv, Sensipar, Pavblu, Imdelltra (Amg757)
- Active ingredients
- Darbepoetin alfa, Adalimumab, Epoetin, Erenumab, Filgrastim, Romosozumab, Apremilast, Sotorasib, Romiplostim, Ivabradine hydrochloride, Etelcalcetide hydrochloride, Cinacalcet hydrochloride
- NDC labeler codes
- 55513
- Strengths
- Romosozumab 105 mg/1.17mL; Aflibercept 2 mg/.05mL; Adalimumab 40 mg/.4mL; Adalimumab 80 mg/.8mL; Adalimumab 40 mg/.8mL; Tezepelumab 210 mg/1.9mL; Erenumab 140 mg/mL; Erenumab 70 mg/mL; Epoetin 10000 [iU]/mL; Pegfilgrastim 4 mg/.4mL; Apremilast 75 mg/1; Eculizumab 300 mg/30mL; Sotorasib 240 mg/1; Apremilast 20 mg/1; Adalimumab 20 mg/.2mL; Adalimumab 10 mg/.2mL; Sotorasib 320 mg/1; Adalimumab 20 mg/.4mL; Sotorasib 120 mg/1; Rituximab 500 mg/50mL
- Dosage forms
- Injection, Solution, Solution, Injection, Kit, Tablet, Coated, Injection, Powder, Lyophilized, For solution, Tablet, Film coated, Injection, Suspension, Injection, Solution, Concentrate
- Routes
- Subcutaneous, Intravenous, Oral, Intravitreal, Intralesional
- Drug classes (FDA established)
- Erythropoiesis-stimulating Agent, Tumor Necrosis Factor Blocker, Leukocyte Growth Factor, Calcium-sensing Receptor Agonist, Vascular Endothelial Growth Factor Inhibitor, Phosphodiesterase 4 Inhibitor, Thrombopoietin Receptor Agonist, Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker, Thymic Stromal Lymphopoietin Blocker, CD20-directed Cytolytic Antibody, HER2/neu Receptor Antagonist, RANK Ligand Inhibitor, Epidermal Growth Factor Receptor Antagonist, Complement Inhibitor
- HCPCS / J-code
- J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mg, J0178 — Injection, aflibercept, 1 mg, J0135 — Injection, adalimumab, 20 mg, J9312 — Injection, rituximab, 10 mg, J1745 — Injection, infliximab, excludes biosimilar, 10 mg, J9355 — Injection, trastuzumab, excludes biosimilar, 10 mg, J9035 — Injection, bevacizumab, 10 mg, J0897 — Injection, denosumab, 1 mg
- Package NDCs
- 135
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Corlanorivabradine | Ivabradine hydrochloride 7.5 mg/1 | Tablet, Film coatedOral | 55513-810 | 55513-0810-60 | — |
| Blincytoblinatumomab | — | Kit | 55513-160 | 55513-0160-0155513-0160-21 | — |
| Xgevadenosumab | Denosumab 120 mg/1.7mL | InjectionSubcutaneous | 55513-730 | 55513-0730-0155513-0730-21 | J0897 |
| Proliadenosumab | Denosumab 60 mg/mL | InjectionSubcutaneous | 55513-710 | 55513-0710-0155513-0710-21 | J0897 |
| Nplateromiplostim | Romiplostim 250 ug/.5mL | Injection, Powder, Lyophilized, For solutionSubcutaneous | 55513-221 | 55513-0221-0155513-0221-21 | — |
| Nplateromiplostim | Romiplostim 500 ug/mL | Injection, Powder, Lyophilized, For solutionSubcutaneous | 55513-222 | 55513-0222-0155513-0222-21 | — |
| Vectibixpanitumumab | Panitumumab 100 mg/5mL | SolutionIntravenous | 55513-954 | 55513-0954-0155513-0954-21 | — |
| Vectibixpanitumumab | Panitumumab 400 mg/20mL | SolutionIntravenous | 55513-956 | 55513-0956-0155513-0956-21 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 25 ug/mL | SolutionIntravenous, Subcutaneous | 55513-002 | 55513-0002-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 40 ug/mL | SolutionIntravenous, Subcutaneous | 55513-003 | 55513-0003-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 60 ug/mL | SolutionIntravenous, Subcutaneous | 55513-004 | 55513-0004-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 100 ug/mL | SolutionIntravenous, Subcutaneous | 55513-005 | 55513-0005-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 200 ug/mL | SolutionIntravenous, Subcutaneous | 55513-006 | 55513-0006-0155513-0006-21 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 150 ug/.3mL | Injection, SolutionIntravenous, Subcutaneous | 55513-027 | 55513-0027-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 25 ug/.42mL | Injection, SolutionIntravenous, Subcutaneous | 55513-057 | 55513-0057-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 10 ug/.4mL | Injection, SolutionIntravenous, Subcutaneous | 55513-098 | 55513-0098-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 40 ug/.4mL | Injection, SolutionIntravenous, Subcutaneous | 55513-021 | 55513-0021-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 60 ug/.3mL | Injection, SolutionIntravenous, Subcutaneous | 55513-023 | 55513-0023-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 100 ug/.5mL | Injection, SolutionIntravenous, Subcutaneous | 55513-025 | 55513-0025-04 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 200 ug/.4mL | Injection, SolutionIntravenous, Subcutaneous | 55513-028 | 55513-0028-01 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 300 ug/.6mL | Injection, SolutionIntravenous, Subcutaneous | 55513-111 | 55513-0111-01 | — |
| Aranespdarbepoetin alfa | Darbepoetin alfa 500 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 55513-032 | 55513-0032-01 | — |
| Sensiparcinacalcet hydrochloride | Cinacalcet hydrochloride 30 mg/1 | Tablet, CoatedOral | 55513-073 | 55513-0073-30 | — |
| Sensiparcinacalcet hydrochloride | Cinacalcet hydrochloride 60 mg/1 | Tablet, CoatedOral | 55513-074 | 55513-0074-30 | — |
| Sensiparcinacalcet hydrochloride | Cinacalcet hydrochloride 90 mg/1 | Tablet, CoatedOral | 55513-075 | 55513-0075-30 | — |
| Neulastapegfilgrastim | Pegfilgrastim 6 mg/.6mL | InjectionSubcutaneous | 55513-190 | 55513-0190-01 | J2506 |
| Neulastapegfilgrastim | — | Kit | 55513-192 | 55513-0192-01 | — |
| Neupogenfilgrastim | Filgrastim 300 ug/.5mL | Injection, SolutionIntravenous, Subcutaneous | 55513-924 | 55513-0924-1055513-0924-2055513-0924-91 | — |
| Neupogenfilgrastim | Filgrastim 480 ug/.8mL | Injection, SolutionIntravenous, Subcutaneous | 55513-209 | 55513-0209-1055513-0209-2055513-0209-91 | — |
| Neupogenfilgrastim | Filgrastim 300 ug/mL | Injection, SolutionIntravenous, Subcutaneous | 55513-530 | 55513-0530-1055513-0530-20 | — |
| Neupogenfilgrastim | Filgrastim 480 ug/1.6mL | Injection, SolutionIntravenous, Subcutaneous | 55513-546 | 55513-0546-1055513-0546-20 | — |
| Epogenepoetin alfa | Epoetin 20000 [iU]/mL | SolutionIntravenous, Subcutaneous | 55513-478 | 55513-0478-1055513-0478-20 | — |
| Epogenepoetin alfa | Epoetin 10000 [iU]/mL | SolutionIntravenous, Subcutaneous | 55513-283 | 55513-0283-1055513-0283-20 | — |
| Epogenepoetin alfa | Epoetin 10000 [iU]/mL | SolutionIntravenous, Subcutaneous | 55513-144 | 55513-0144-1055513-0144-20 | — |
| Epogenepoetin alfa | Epoetin 4000 [iU]/mL | SolutionIntravenous, Subcutaneous | 55513-148 | 55513-0148-1055513-0148-20 | — |
| Epogenepoetin alfa | Epoetin 3000 [iU]/mL | SolutionIntravenous, Subcutaneous | 55513-267 | 55513-0267-1055513-0267-20 | — |
| Epogenepoetin alfa | Epoetin 2000 [iU]/mL | SolutionIntravenous, Subcutaneous | 55513-126 | 55513-0126-1055513-0126-20 | — |
Amgen, Inc: common questions
- What is Amgen, Inc's NDC labeler code?
- 55513. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Amgen, Inc?
- Med-Code's HCPCS directory matches J2506, J0178, J0135, J9312, J1745, J9355, J9035, J0897 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.